Financhill
Back

PTC Therapeutics Quote, Financials, Valuation and Earnings

PTC Therapeutics Price Quote

$28.61
+0.04 (+12.24%)
(Updated: April 27, 2024 at 6:17 AM ET)

PTC Therapeutics Key Stats

Sell
47
PTC Therapeutics (PTCT) is a Sell

Day range:
$25.67 - $29.27
52-week range:
$17.53 - $59.84
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.28
P/B ratio:
0%

Volume:
1.5M
Avg. volume:
857.6K
1-year change:
-45.31%
Market cap:
$2.2B
Revenue:
$937.8M
EPS:
$-8.36

How Much Does PTC Therapeutics Make?

Is PTC Therapeutics Growing As A Company?

  • What Is PTC Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.83%
  • What Is PTC Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

PTC Therapeutics Stock Price Performance

  • Did PTC Therapeutics Stock Go Up Last Month?
    PTC Therapeutics share price went up by 2.18% last month
  • Did PTCT's Share Price Rise Over The Last Year?
    PTCT share price fell by -45.31% over the past 1 year

What Is PTC Therapeutics 52-Week High & Low?

PTC Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy PTC Therapeutics?

  • How Much Debt Does PTC Therapeutics Have?
    Total long term debt quarterly is $2.1B
  • How Much Cash Does PTC Therapeutics Have?
    Cash and short term investments quarterly total is $876.7M
  • What Is PTC Therapeutics’s Book Value Per Share?
    Book value per share is -10.81

Is PTC Therapeutics Cash Flow Positive?

  • What Is PTCT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$158.4M
  • What Is PTC Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $646.4M
  • What Is PTC Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$176.7M

PTC Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    PTCT return on invested capital is -137.86%
  • What Is PTC Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -40.13%
  • What Is PTCT Return On Equity?
    ROE is a measure of profitability and is 0%

PTC Therapeutics Earnings Date & Stock Price

PTC Therapeutics Competitors

  • Who Are PTC Therapeutics's Competitors?
    Below is a list of companies who compete with PTC Therapeutics or are related in some way:
    • Perspective Therapeutics Inc (CATX)
    • Catalyst Pharmaceuticals Inc (CPRX)
    • Geron Corp (GERN)
    • Pfizer Inc (PFE)
    • Sarepta Therapeutics Inc (SRPT)

PTC Therapeutics Dividend Yield

Data Unavailable

PTC Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -9.09%
Revenue: 83.41% 22.09%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 5
Sell Recommendations: 1
Price Target: 29.42
Upside from Last Price: 2.96%

Major Shareholders

  • How many PTCT shares are owned by institutional investors?
    137.4M PTCT shares are owned by institutional investors
  • How many PTCT shares are owned by insiders?
    1.3M PTCT shares are owned by insiders